Sanofi is negotiating a deal to sell a controlling stake in its Consumer Healthcare division enabling the French firm to retain a substantial share of the business.
Private Equity Poised To Take Control Of Opella But Sanofi Will Retain Sizable Stake
Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.